These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5765044)

  • 1. Staphylococcal spheroplasts and L-colonies. 3. Induction by lysostaphin.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    J Infect Dis; 1969 Jan; 119(1):67-74. PubMed ID: 5765044
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
    Huber TW; Schuhardt VT
    J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal spheroplasts and L colonies. IV. Antimicrobial susceptibility of stable methicillin-induced and lysostaphin-induced spheroplasts.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():382-7. PubMed ID: 5195739
    [No Abstract]   [Full Text] [Related]  

  • 4. Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.
    Schuhardt VT; Klesius PH
    J Bacteriol; 1968 Sep; 96(3):734-7. PubMed ID: 5732506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopy.
    Fass RJ
    J Bacteriol; 1973 Feb; 113(2):1049-53. PubMed ID: 4570589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the composition of the reversion medium on the transformation of coccal forms and L-form of Staphylococcus aureus lysostaphin protoplasts].
    Kato Y; Hirachi Y; Toda Y; Kurono M; Takemasa N; Kotani S
    Osaka Daigaku Shigaku Zasshi; 1985 Dec; 30(2):296-303. PubMed ID: 3869230
    [No Abstract]   [Full Text] [Related]  

  • 7. Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts.
    Schuhardt VT; Huber TW; Pope LM
    J Bacteriol; 1969 Jan; 97(1):396-401. PubMed ID: 5764340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin.
    Watanakunakorn C; Fass RJ; Klainer AS; Hamburger M
    Infect Immun; 1971 Jul; 4(1):73-8. PubMed ID: 4949481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and pathogenicity of microbial spheroplasts and l-forms.
    Feingold DS
    N Engl J Med; 1969 Nov; 281(21):1159-70. PubMed ID: 4899869
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfection of lysostaphin-treated cells of Staphylococcus aureus.
    Riggs HG; Rosenblum ED
    J Virol; 1969 Jan; 3(1):33-7. PubMed ID: 4239098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the composition of reversion medium on change of Staphylococcus aureus lysostaphin protoplasts to coccal forms and L-forms.
    Kato Y; Hirachi Y; Toda Y; Takemasa N; Kotani S
    Biken J; 1986 Jun; 29(2):39-44. PubMed ID: 3814073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal spheroplasts and L colonies. I. Population curves of vegetative staphylococci and spheroplasts in methicillin-containing broth over long periods.
    Hamburger M; Carleton J
    J Infect Dis; 1966 Apr; 116(2):221-30. PubMed ID: 5910275
    [No Abstract]   [Full Text] [Related]  

  • 13. Fosfomycin-induced protoplasts and L-forms of Staphylococcus aureus.
    Schmid EN
    Chemotherapy; 1984; 30(1):35-9. PubMed ID: 6692720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal conditions for producing protoplasts in Staphylococcus aureus using lysozyme].
    Ignatov VV; Panasenko VI; Kuliash IuV; Veselkina AL; Shmyglia LN
    Mikrobiologiia; 1973; 42(4):703-7. PubMed ID: 4598498
    [No Abstract]   [Full Text] [Related]  

  • 15. Lysostaphin.
    Koening MG
    J Infect Dis; 1969 Jan; 119(1):101-2. PubMed ID: 5191239
    [No Abstract]   [Full Text] [Related]  

  • 16. L forms, spheroplasts and aberrant forms in chronic sepsis.
    Louria DB
    Adv Intern Med; 1971; 17():125-42. PubMed ID: 4126005
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lysostaphin and its two active components on stable wall-defective forms of Staphylococcus aureus.
    Watanakunakorn C; Browder HP
    J Infect Dis; 1970 Feb; 121(2):124-8. PubMed ID: 5197995
    [No Abstract]   [Full Text] [Related]  

  • 18. The accumulation of extracellular macromolecules by Staphylococcus aureus grown in the presence of sodium chloride and glucose.
    Cripps RE; Work E
    J Gen Microbiol; 1967 Oct; 49(1):127-37. PubMed ID: 6064440
    [No Abstract]   [Full Text] [Related]  

  • 19. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 20. Staphylococcal spheroplasts and L colonies. II. Conditions conducive to reversion of spheroplasts to vegetative staphylococci.
    Hamburger M; Carleton J
    J Infect Dis; 1966 Dec; 116(5):544-50. PubMed ID: 5957261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.